The Modulating Effects of Benign Prostate Enlargement Medications on Upgrading Predictors in Patients with Gleason 6 at Biopsy

Publisher： Karger

E-ISSN： 1661-7657|10|2|97-104

ISSN： 1661-7649

Source： Current Urology, Vol.10, Iss.2, 2017-05, pp. : 97-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gleason Score 6 - Prostate Cancer or Benign Variant?

By  

Oncology Research and Treatment, Vol. 38, Iss. 12, 2015-0 ,pp. : 629-632

Karger

Access to resources Recommend Favorite

Incidence of Upgrading and Upstaging in Patients with Low-Volume Gleason Score 3+4 Prostate Cancers at Biopsy: Finding a New Group Eligible for Active Surveillance

By  

Urologia Internationalis, Vol. 90, Iss. 3, 2013-02 ,pp. : 301-305

Karger

Access to resources Recommend Favorite

Development and multi‐institutional validation of an upgrading risk tool for Gleason 6 prostate cancer

By  

CANCER, Vol. 119, Iss. 22, 2013-11 ,pp. : 3992-4002

John Wiley & Sons Inc

Access to resources Recommend Favorite

High Testosterone Preoperative Plasma Levels Independently Predict Biopsy Gleason Score Upgrading in Men with Prostate Cancer Undergoing Radical Prostatectomy

By  

Urologia Internationalis, Vol. 96, Iss. 4, 2016-02 ,pp. : 470-478

Karger

Access to resources Recommend Favorite

Clinical role of pathological downgrading after radical prostatectomy in patients with biopsy confirmed Gleason score 3 + 4 prostate cancer

By  

BJU INTERNATIONAL, Vol. 115, Iss. 1, 2015-01 ,pp. : 81-86

John Wiley & Sons Inc

Access to resources Recommend Favorite